Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Imidazole | HCID 795 | — |
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | 4,7-Dimethoxy-1,10-phenanthroline | HCID 10462298 | — |
| Reactant | 3-(4-Bromo-2-methylphenyl)-7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2,6-dimethylpyrazolo[5,1-b]oxazole | HCID 59186081 | — |
| Solvent | N-methyl-2-pyrrolidone | HCID 13387 | — |
| Product | HCID 67212625 | HCID 67212625 | — |
Reaction Steps
3-(4-Bromo-2-methylphenyl)-7-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-2,6-dimethyl pyrazolo[5,1-b]oxazole (Ex. 6.41) (40 mg, 0.100 mmol), 4,7-dimethoxy-1,10-phenanthroline (24.01 mg, 0.100 mmol), 1H-imidazole (8.16 mg, 0.120 mmol), Cu2O (0.715 mg, 5.00 μmol) and Cs2CO3 (45.6 mg, 0.140 mmol) are added to NMP (2 ml) and stirred at 110° C. for 5 days.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07994203B2 |
|---|
| Source dataset | uspto-grants-2011_08 |
|---|
| ORD ID | ord-bc7da72c62cf40029d1947941721b3b5 |
|---|
| Source note | uspto-grants-2011_08 |
|---|
